None listed
Conditions
Interventions
Intervention1: Anti Rabies Vaccine: The antirabies vaccine will be administered as a single dose of 0.1 ml on day 0 via the intradermal route at two sites, one over each deltoid, as pre-exposure proph
Sponsors
Maulana Azad Medical College and Lok Nayak Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Children and adolescents aged 1-18 years from OPD / with minor illnesses.
Exclusion criteria
Exclusion criteria: 1.History of receipt of any rabies vaccine in the 2.Past History of animal bite. 3. Previous severe allergic reaction to any of the vaccine components. 4.Known history of autoimmune disease, immunodeficiency disorders or chronic diseases. 5.History of receipt of any vaccine within 1 month. 6.History of dog bite during the study period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of subjects with IgG anti rabies virus glycoprotein titres equal to or more than 0.5 EU/ml 28 days after single dose of Intradermal Pre exposure Rabies Prophylaxis. Timepoint: Baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Proportion of subjects with IgG anti rabies virus glycoprotein titres equal to or more than 0.5 EU/ml 180 days after single dose of Intradermal Pre exposure Rabies Prophylaxis.. 2.Proportion & profile of adverse effects in children, following single dose intradermal pre-exposure rabies prophylaxisTimepoint: Day 180 Where day 0 will be day of administration of vaccine | — |
Countries
India
Contacts
Public ContactDr Anurag Agarwal
Maulana Azad Medical College
Outcome results
None listed